Showing 7,341 - 7,360 results of 29,133 for search '(( 5 step decrease ) OR ( 50 ((((we decrease) OR (nn decrease))) OR (a decrease)) ))', query time: 1.08s Refine Results
  1. 7341
  2. 7342

    Tgfβ and p53 response in the SDS pancreas. by Marina E. Tourlakis (751986)

    Published 2015
    “…<p><b>A,</b> Steady state protein levels paralleled observed transcript changes with decreased Myc and increased p21<sup>Cip</sup> and Tgfβ expression, along with changes in Smad2 and Smad3 phosphorylation status in mutants. …”
  3. 7343
  4. 7344
  5. 7345
  6. 7346

    Lead Optimization of Androgen Receptor-HSP27 Disrupting Agents in Glioblastoma by Yaxin Li (312731)

    Published 2023
    “…Compounds <b>4</b> and <b>6</b> exhibit IC<sub>50</sub>s of 35 and 23 nM, respectively, to inhibit cell proliferation and also show significant activity to decrease the tumor growth <i>in vivo</i>.…”
  7. 7347
  8. 7348
  9. 7349

    Management of Recurrent Bronchopleural Fistula: A Multidisciplinary Approach for A Reconstructive Challenge by Karishma Chandarana (4607131)

    Published 2022
    “…<p> </p> <p>Urgent pneumonectomy for benign disease is rare but highly morbid, with a perioperative mortality approaching 50 percent. …”
  10. 7350

    Depletion of TPX2 causes defects in 53BP1 ionizing radiation-induced foci formation. by Gernot Neumayer (77179)

    Published 2014
    “…<p>(A) The protein level of 53BP1 is not affected by miRNA-mediated depletion of TPX2. …”
  11. 7351
  12. 7352

    Sample means, SDs, and selected correlations. by Erik Lykke Mortensen (7239170)

    Published 2025
    “…Educational attainment was a particularly strong predictor of status attainment. …”
  13. 7353
  14. 7354
  15. 7355
  16. 7356
  17. 7357
  18. 7358

    Novel Antagonist of the Type 2 Lysophosphatidic Acid Receptor (LPA<sub>2</sub>), UCM-14216, Ameliorates Spinal Cord Injury in Mice by Nora Khiar-Fernández (8130210)

    Published 2022
    “…Toward validating this receptor as a target in SCI, we have developed a new series of LPA<sub>2</sub> antagonists, among which compound <b>54</b> (UCM-14216) stands out as a potent and selective LPA<sub>2</sub> receptor antagonist (<i>E</i><sub>max</sub> = 90%, IC<sub>50</sub> = 1.9 μM, <i>K</i><sub>D</sub> = 1.3 nM; inactive at LPA<sub>1,3–6</sub> receptors). …”
  19. 7359

    Novel Antagonist of the Type 2 Lysophosphatidic Acid Receptor (LPA<sub>2</sub>), UCM-14216, Ameliorates Spinal Cord Injury in Mice by Nora Khiar-Fernández (8130210)

    Published 2022
    “…Toward validating this receptor as a target in SCI, we have developed a new series of LPA<sub>2</sub> antagonists, among which compound <b>54</b> (UCM-14216) stands out as a potent and selective LPA<sub>2</sub> receptor antagonist (<i>E</i><sub>max</sub> = 90%, IC<sub>50</sub> = 1.9 μM, <i>K</i><sub>D</sub> = 1.3 nM; inactive at LPA<sub>1,3–6</sub> receptors). …”
  20. 7360

    Synthesis and Biological Evaluation of Peripheral 5HT<sub>2B</sub> Antagonists for Liver Fibrosis by Jihyeon Yoon (8705706)

    Published 2025
    “…<b>19c</b> markedly reduced fibrotic deposition, with a decrease in fibrosis stage and area in the CCl<sub>4</sub>-induced liver fibrosis mouse model. …”